Documente Academic
Documente Profesional
Documente Cultură
ORIGINAL CONTRIBUTIONS
ARTICLE 2
abstract
Background. Hemostatic agents have been used clinically in
dentistry for many years to control bleeding. The authors reviewed
scientific publications in which researchers investigated the effects of
hemostatic agents on dentin and enamel surfaces and on bonding of
adhesive systems and resin cements.
Types of Studies Reviewed. The authors screened PubMed
and Scopus databases for studies in English published from 1980
to 2013. They read the titles and abstracts to identify literature that
fulfilled the inclusion criteria. The authors included studies in which
researchers evaluated the hemostatic action on the dentin and enamel
surfaces or its influence on the bond strength of adhesive systems or
resin cements. They used cross-referencing to identify more articles.
Results. Twenty in vitro studies met the inclusion criteria. Investigators in 12 of these studies evaluated the bond strength to contaminated dentin. Investigators in 10 of these studies reported a significant decrease in bond strength. Those in two studies evaluated the
influence of a hemostatic agent on the dental enamel and reported
decreases in bond strength. Researchers also reported significant
increases in microleakage of self-etching adhesives on contaminated
dentin. Scanning electron microscopy revealed partial removal of the
smear layer or an etching effect of dentin as a result of the application
of hemostatic agents on dentin.
Practical Implications. Adhesive procedures may be affected
adversely when performed on dentin and enamel contaminated by
hemostatic agents. Hemostatic agents may induce changes in the
dentin surface morphology. The results of this review indicate that
the bond strength of self-etching adhesive systems is affected more
negatively than is that of etch-and-rinse systems. The authors found
that a 60-second application of ethylenediaminetetraacetic acid followed by a water spray restored the bond strength of a self-etching
adhesive to dentin; use of phosphoric acid for 15 seconds followed by
a water spray also was an effective cleaning method. Direct comparison of selected studies was not possible, however, mainly because of
methodological differences hampering definitive conclusions.
Key Words. Bonding agents; adhesives; aluminum chloride; cementation; dental adhesives; dental bonding; hemostasis.
JADA 2014;145(11):1120-1128.
doi:10.14219/jada.2014.84
ORIGINAL CONTRIBUTIONS
which researchers evaluated the cytotoxicity of hemostatic agents on human gingival fibroblasts.
Data extraction. One of us (K.O.B.) extracted the following data from the included studies and entered them
into electronic spreadsheets: authors, year of publication,
hemostatic agent, contamination time, cleaning method,
adhesive system or resin cement, bond strength test and
any other tests used (Table 112-31). We did not perform any
statistical analysis or meta-analysis owing to both methodological differences and differences in the combinations of
materials used to create the experimental groups.
METHODS
RESULTS
The searches yielded 574 citations. In total, we investigated 33 full-text studies, 20 of which qualified for this
review (Figure 1, page 1124). We did not locate any additional articles by means of cross-referencing.
All of the investigations were in vitro laboratory
studies published in English. Investigators in all but
two studies22,29 used extracted human teeth, and those
in three of the 18 studies used primary teeth.15,18,23 We
ORIGINAL CONTRIBUTIONS
TABLE 1
HEMOSTATIC
AGENT *
Land and
Colleagues,12
1994
Astringedent
Land and
Colleagues,13
1996
CONTAMINATION
TIME
CLEANING
METHOD
ADHESIVE
SYSTEM
OR
LUTING AGENT
BOND
STRENGTH
TEST
SURFACE
ANALYSIS OR
OTHER TEST
None
Not
conducted
SEM
Astringedent,
30 seconds/
Hemogin L,
two minutes/fi ve
Hemodent,
minutes
Cranberry Styptin,
Gingi-Aid
Astringent 25%,
Orostat 8%, Visine
Original, Ocuclear
None
Not
conducted
SEM
Ayo-Yusuf and
Colleagues,14
2005
Hemodent,
Astringedent,
Ultradent buffered
25% aluminum
chloride
30 seconds/
one minute/two
minutes/
fi ve minutes
Air-water spray
for 10 seconds
None
Not
conducted
SEM, EDS
Salama,15 2005
Astringedent
48 hours
SBS
None
Kimmes and
Colleagues,16
2006
ViscoStat,
ViscoStat Plus
One minute
OptiBond Solo
Plus
SBS
None
Kuphasuk and
Colleagues,17
2007
Racestyptine
Two minutes
Clearfil SE Bond,
Excite
Micro-SBS
SEM, EDS
Prabhakar and
Bedi,18 2008
Astringedent
48 hours
Adper Prompt
L- Pop, Clearfil SE
Bond
SBS
None
Two minutes
ED Primer II/
Panavia F, Excite
DSC/Variolink II
Micro-SBS
SEM, EDS
30 seconds/
two minutes/fi ve
minutes
* The manufacturers of the hemostatic agents are as follows: Astringedent, Ultradent Products, South Jordan, Utah; Hemogin L, Dux Dental, Oxnard,
Calif.; Hemodent, Premier Dental Products, Plymouth Meeting, Pa.; Cranberry Styptin, Dux Dental; Gingi-Aid Astringent 25%, Gingi-Pak, a division
of The Belport Co., Camarillo, Calif.; Orostat 8%, Gingi-Pak; Visine Original, McNeil-PPC, Lancaster, Pa.; Ocuclear, Health Care Products, Memphis,
Tenn.; Ultradent buffered 25% aluminum chloride, Ultradent Products; ViscoStat, ViscoStat Plus and ViscoStat Clear, Ultradent Products; Racestyptine,
Septodont, Saint-Maur-des-Fosss, France; Ferric Subsulfate Dental Gel, Bealls Compounding Pharmacy, Puyallup, Wash.; Ankaferd Blood Stopper,
Ankaferd, Istanbul; Hemostop, Dentsply International, York, Pa.
The manufacturers of the adhesive systems or luting agents are as follows: Prime & Bond NT, Dentsply, York, Pa.; OptiBond Solo Plus, Kerr, Orange,
Calif.; Clearfil SE Bond, Kuraray, Tokyo; Excite, Ivoclar Vivadent, Schaan, Liechtenstein; Adper Prompt L-Pop, 3M ESPE, St. Paul, Minn.; ED Primer II
and Panavia F, Kuraray; Excite DSC and Variolink II, Ivoclar Vivadent; Rely X Unicem, 3M ESPE; All Bond SE, Bisco, Schaumburg, Ill.; Solobond M,
VOCO, Cuxhaven, Germany; Clearfil Tri-S Bond, Kuraray; Adper Easy One, 3M ESPE; AdheSE and AdheSE One, Ivoclar Vivadent; Tetric N-Bond, Ivoclar
Vivadent; Single Bond, 3M ESPE; iBond, Heraeus Kulzer, Hanau, Germany; Transbond XT, 3M Unitek, Monrovia, Calif.; Clearfil S3 Bond, Kuraray; Light
Bond, Reliance Orthodontic Products, Itasca, Ill.
SEM: Scanning electron microscopy.
EDS: Energy-dispersive spectroscopy.
SBS: Shear bond strength.
# EDTA: Ethylenediaminetetraacetic acid.
ORIGINAL CONTRIBUTIONS
TABLE 1 (continued)
SOURCE
HEMOSTATIC
AGENT *
CONTAMINATION
TIME
CLEANING
METHOD
ADHESIVE
SYSTEM
OR
LUTING AGENT
BOND
STRENGTH
TEST
SURFACE
ANALYSIS OR
OTHER TEST
Chaiyabutr and
Kois,20 2011
ViscoStat Clear,
Ferric Subsulfate
Dental Gel
Five minutes
Rely X Unicem
SBS
SEM
Arslan and
Colleagues, 21
2012
Ankaferd Blood
Stopper
Not specified
Clearfil SE Bond,
All Bond SE,
Solobond M
SBS
SEM
Mohammadi and
Colleagues, 22
2012
Hemostop
Two minutes
Not conducted
Microleakage
Shalan and
Colleagues, 23
2012
Astringedent
48 hours
AdheSE One
SBS
SEM, Fourier
transform
infrared
spectroscopy
Ajami and
Colleagues, 24
2013
Hemostop
Two minutes
SBS
SEM, EDS
Arslan and
Colleagues, 25
2013
Ankaferd Blood
Stopper
Not specified
Clearfil SE Bond,
Adper Easy One
Not conducted
Microleakage
Ebrahimi and
Colleagues, 26
2013
ViscoStat
60 seconds
AdheSE, AdheSE
One,
Tetric N-Bond
SBS
None
Kumar and
Colleagues, 27
2012
ViscoStat
10 seconds
Single Bond,
iBond
Not conducted
Microleakage
Kilic and
Colleagues, 28
2013
Ankaferd Blood
Stopper
20 seconds
ED Primer II/
Panavia F
Microtensile
bond strength
None
Trakyali and
Oztoprak, 29 2010
Ankaferd Blood
Stopper
Not specified
Transbond XT
SBS
None
Ulusoy and
Colleagues, 30
2011
Ankaferd Blood
Stopper
10 seconds
Microtensile
bond strength
None
Gngr and
Colleagues, 31
2013
Ankaferd Blood
Stopper
Not specified
Light Bond
SBS
None
Duplicated articles
(n = 25)
Included
Eligibility
Screening
Identification
ORIGINAL CONTRIBUTIONS
Full-text articles
assessed for eligibility
(n = 58)
Records excluded
(n = 516)
Studies included in
systematic review
(n = 20)
In this review, we selected studies pertaining to hemostatic effects on both dentin and enamel surfaces and
dentin and enamel bonding. Because the use of hemostatic agents is routine in clinical procedures, understanding their effects on dentin morphology, as well as
on the enamel surface and on bonding, is of unquestionable importance. However, owing to the lack of similarities in methodological criteria between the studies in our
review, we found it difficult to draw definitive conclusions. Crossover analysis among studies was limited
because of the few similarities between them; therefore,
conducting a statistical analysis was not feasible.
Hemostatic agents are acidic solutions, with pH values ranging from 0.7 to 2.0.12-14,17,19 Aluminum chloride
and ferric sulfate were the main active ingredients in
ORIGINAL CONTRIBUTIONS
TABLE 2
MANUFACTURER
ACTIVE
INGREDIENT *
Astringedent
Ultradent Products,
South Jordan, Utah
Ultradent Buffered
Aluminum Chloride
Ultradent Products
25 percent aluminum
chloride solution
ViscoStat
Ultradent Products
20 percent ferric
sulfate solution
ViscoStat Plus
Ultradent Products
22 percent ferric
chloride solution
ViscoStat Clear
Ultradent Products
25 percent aluminum
chloride gel
Ferric Subsulfate
Dental Gel
Bealls Compounding
Pharmacy, Puyallup,
Wash.
13 percent ferric
sulfate gel
Hemogin L
25 percent aluminum
chloride aqueous
solution
Hemodent
Premier Dental
Products, Plymouth
Meeting, Pa.
21.3 percent
aluminum chloride
aqueous/glycol
solution
Cranberry Styptin
Dux Dental
20 percent aluminum
chloride buffered
glycol solution
Gingi-Aid
Astringent 25%
Gingi-Pak, a division
of The Belport Co.,
Camarillo, Calif.
25 percent aluminum
chloride solution
Orostat 8%
Gingi-Pak
8 percent racemic
epinephrine solution
Visine Original
McNeil-PPC,
Lancaster, Pa.
Tetrahydrozoline
hydrochloride
solution
Ocuclear
Racestyptine
Septodont, SaintMaur-des-Fosss,
France
25 percent aluminum
chloride solution
Hemostop
Dentsply
International, York,
Pa.
Aluminum chloride
solution
Ankaferd Blood
Stopper
Ankaferd, Istanbul
e
ate
ulf lorid
h
ic S
err rric C
tF
en nt Fe
c
r
Pe
rce
20 2 Pe
2
50
40
30
25 Percent
Aluminum Chloride
25 Percent
Aluminum Chloride
20
Ankaferd
Blood Stopper
Ankaferd
Blood Stopper
15.5 Percent
Ferric Sulfate
20 Percent
Ferric Sulfate
15.5 Percent
Ferric Sulfate
Aluminum Chloride
e
Ankaferd
Blood Stopper
10
15.5 Percent
Ferric Sulfate
rid
nt Chlo
rce
Pe um
25 min nt
Alu erce lfate
P Su
13 rric
Fe
Co
lle
ag
ue Ki
s, 2 lic
8
a
20 nd
13
Co
lle
ag A
ue jam
s, 2 i
4
a
20 nd
13
Co
lle
ag Sh
ue ala
s, 2 n
3
a
20 nd
12
Ch
ai
y
Ko ab
is 2 utr
, 0 a
20 nd
11
Pr
ab
Be ha
di ka
, 18 r a
20 nd
08
Co
lle Eb
ag ra
ue him
s, 2 i
6
a
20 nd
13
Co
lle K
ag im
ue m
s, 1 es
6
a
20 nd
06
Co
lle
ag Ar
ue sla
s, 2 n
1
a
20 nd
12
5
a, 1
5
20
0
Sa
la
m
Co
lle
ag Ulu
ue so
s, 3 y
0
a
20 nd
11
0
Co K
lle up
ag ha
ue su
s, 1 k
7
a
20 nd
07
Co Ha
lle rni
ag rat
ue tis
s, 1 ai
9
a
20 nd
09
ORIGINAL CONTRIBUTIONS
STUDY
Etch-and Rinse Adhesives
Self-Adhesive Cement
Uncontaminated Dentin
Uncontaminated Dentin
Uncontaminated Dentin
Uncontaminated Dentin
Contaminated Dentin
Contaminated Dentin
Contaminated Dentin
Contaminated Dentin
Figure 2. Bond strength test results of studies performed on dentin. Ankaferd Blood Stopper is manufactured by Ankaferd, Istanbul.
ORIGINAL CONTRIBUTIONS
ORIGINAL CONTRIBUTIONS